Clinical Trial Update: Assessing Short and Long Term Compliance With Caloric Intake in HIV Positive Women Taking Complera

View source ↗

Summary

This clinical trial update reports on short- and long-term compliance with caloric intake in HIV-positive women taking Complera (rilpivirine/emtricitabine/tenof…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• COMPLERA (Emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate)

Snippet

Sponsor: Prema Menezes, PhD, PA-C | Conditions: HIV-1 Infection | Status: COMPLETED